A method for constructing a liver cancer lung pre-metastasis niche mouse model associated with hardness
By constructing and applying tumor-free mouse models, we have solved the problems of stiffness-related animal experiments, especially for constructing tumor-free models and for studying stiffness-related animal models. We have also solved the construction method of stiffness-related liver cancer lung pre-metastatic niche mouse models, and solved the technical problems and difficulties. In particular, we have solved the experimental research on stiffness-related liver cancer lung pre-metastatic niches by constructing and applying tumor-free mouse models.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHONGSHAN HOSPITAL FUDAN UNIV
- Filing Date
- 2024-06-17
- Publication Date
- 2026-06-23
AI Technical Summary
The existing technology lacks an ideal animal model that can fully simulate the pre-metastatic niche of liver cancer in the lungs, especially a tumor-free mouse model, making it difficult to accurately assess the regulatory mechanism of matrix stiffness on the formation of distal pre-metastatic niches in liver cancer.
A method combining in vitro conditioned culture supernatant acquisition and in vivo injection induction was employed. Conditioned culture supernatant of mouse hepatocellular carcinoma cells growing on low and high hardness substrates was extracted in vitro to simulate soluble factors of primary hepatocellular carcinoma tumors in normal and high hardness backgrounds. These factors were then injected into mice via tail vein once a day until day 26. The recruitment of BMDCs in fresh lung tissue was detected to define the time point of lung pre-metastatic niche formation, supplemented by the detection of pre-metastatic niche marker characteristics at the induction endpoint.
A characteristic model capable of accurately assessing the formation of pre-metastatic niches in the lungs of hepatocellular carcinoma was constructed, including tumor-free mouse models of BMDC recruitment, matrix remodeling, inflammation, immunosuppression, angiogenesis, vascular permeability, and inflammation. The model can accurately simulate tumor-free mouse models with high and low lung tissue matrix remodeling, immunosuppression, angiogenesis, vascular permeability, and inflammation. The model can accurately reflect the characteristics of the model, solving the technical problem of stiffness-related animal models and achieving technical solutions to the technical problem.
Smart Images

Figure CN118633568B_ABST